Marisa Cabeza

1.1k total citations
82 papers, 940 citations indexed

About

Marisa Cabeza is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Marisa Cabeza has authored 82 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Endocrinology, Diabetes and Metabolism, 37 papers in Molecular Biology and 32 papers in Genetics. Recurrent topics in Marisa Cabeza's work include Hormonal and reproductive studies (53 papers), Estrogen and related hormone effects (32 papers) and Prostate Cancer Treatment and Research (21 papers). Marisa Cabeza is often cited by papers focused on Hormonal and reproductive studies (53 papers), Estrogen and related hormone effects (32 papers) and Prostate Cancer Treatment and Research (21 papers). Marisa Cabeza collaborates with scholars based in Mexico, Puerto Rico and Vietnam. Marisa Cabeza's co-authors include Eugene Bratoeff, Ivonne Heuze, Elena Ramı́rez, Eugenio Flores, M. Revilla, Rubén Román‐Ramos, Gregorio Pérez‐Palacios, Araceli Sánchez, Ricardo A. Valdez and José Segovia and has published in prestigious journals such as Fertility and Sterility, European Journal of Medicinal Chemistry and Current Medicinal Chemistry.

In The Last Decade

Marisa Cabeza

77 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marisa Cabeza Mexico 18 404 379 281 142 123 82 940
Eugene Bratoeff Mexico 18 474 1.2× 336 0.9× 257 0.9× 139 1.0× 176 1.4× 83 988
Kenneth Ellsworth United States 17 593 1.5× 300 0.8× 84 0.3× 53 0.4× 140 1.1× 25 1.2k
Kapila Ratnam United States 12 571 1.4× 462 1.2× 215 0.8× 103 0.7× 95 0.8× 15 1.4k
D. Giudici Italy 16 287 0.7× 155 0.4× 466 1.7× 114 0.8× 24 0.2× 28 744
Michael C. Byrns United States 16 386 1.0× 317 0.8× 131 0.5× 210 1.5× 135 1.1× 16 1.2k
Scott G. Lundeen United States 23 384 1.0× 354 0.9× 460 1.6× 79 0.6× 515 4.2× 47 1.4k
J.C. Nwachukwu United States 20 550 1.4× 87 0.2× 420 1.5× 61 0.4× 187 1.5× 33 1.2k
Martin Frotscher Germany 19 390 1.0× 686 1.8× 722 2.6× 25 0.2× 359 2.9× 46 1.2k
Julie Jones United States 15 316 0.8× 83 0.2× 109 0.4× 148 1.0× 64 0.5× 25 1.0k
Jesús Sánchez‐Yagüe Spain 20 493 1.2× 98 0.3× 92 0.3× 81 0.6× 46 0.4× 54 1.1k

Countries citing papers authored by Marisa Cabeza

Since Specialization
Citations

This map shows the geographic impact of Marisa Cabeza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Cabeza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Cabeza more than expected).

Fields of papers citing papers by Marisa Cabeza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Cabeza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Cabeza. The network helps show where Marisa Cabeza may publish in the future.

Co-authorship network of co-authors of Marisa Cabeza

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Cabeza. A scholar is included among the top collaborators of Marisa Cabeza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Cabeza. Marisa Cabeza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabeza, Marisa, et al.. (2025). Inhibition of Steroidogenesis in Prostate Cancer Cells by Both a Natural and Another Synthetic Steroid. Drug Development Research. 86(2). e70078–e70078.
2.
Cabeza, Marisa, et al.. (2023). Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells. Oriental Journal Of Chemistry. 39(3). 523–532. 1 indexed citations
3.
Bratoeff, Eugene, et al.. (2015). Synthesis and Identification of Pregnenolone Derivatives as Inhibitors of Isozymes of 5α‐Reductase. Archiv der Pharmazie. 348(11). 808–816. 6 indexed citations
4.
González‐Arenas, Aliesha, et al.. (2015). Effect of new hybrids based on 5,16-pregnadiene scaffold linked to an anti-inflammatory drug on the growth of a human astrocytoma cell line (U373). European Journal of Medicinal Chemistry. 93. 135–141. 7 indexed citations
5.
Cabeza, Marisa, et al.. (2014). Recent advances in structure of progestins and their binding to progesterone receptors. Journal of Enzyme Inhibition and Medicinal Chemistry. 30(1). 152–159. 13 indexed citations
6.
Cabeza, Marisa, et al.. (2013). Cytotoxic effect of novel dehydroepiandrosterone derivatives on different cancer cell lines. European Journal of Medicinal Chemistry. 68. 301–311. 16 indexed citations
7.
Cabeza, Marisa, et al.. (2012). Molecular interactions of natural and synthetic steroids in female hamsters’ flank organs. Journal of Dermatological Science. 66(2). 119–126. 1 indexed citations
9.
Cabeza, Marisa, et al.. (2008). Biological activity of novel progesterone derivatives having a bulky ester side chains at C-3. Steroids. 73(8). 838–843. 14 indexed citations
10.
Bratoeff, Eugene, Marisa Cabeza, Ivonne Heuze, et al.. (2007). Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5α-reductase. The Journal of Steroid Biochemistry and Molecular Biology. 107(1-2). 48–56. 18 indexed citations
11.
Cabeza, Marisa, et al.. (2007). Antiandrogenic and apoptotic effects of RU-486 on animal prostate. The Journal of Steroid Biochemistry and Molecular Biology. 104(3-5). 321–325. 3 indexed citations
12.
Cabeza, Marisa, et al.. (2006). Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomedicine & Pharmacotherapy. 60(4). 161–168. 79 indexed citations
13.
Cabeza, Marisa, Eugene Bratoeff, Ivonne Heuze, et al.. (2006). New progesterone derivatives as inhibitors of 5α-reductase enzyme and prostate cancer cell growth. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(4). 371–378. 14 indexed citations
14.
Bratoeff, Eugene, et al.. (2005). Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors. Current Medicinal Chemistry. 12(8). 927–943. 18 indexed citations
15.
Radhika, P., et al.. (2004). 5α-Reductase inhibition activity of steroids isolated from marine soft corals. Steroids. 69(7). 439–444. 18 indexed citations
16.
Ramı́rez, Elena, et al.. (2001). Crystal Structure and Synthesis of 17α-Hexanoyloxy-16β-methylpregna-4,6-diene-3,20-dione. Analytical Sciences. 17(10). 1245–1246. 2 indexed citations
17.
Cabeza, Marisa, et al.. (1999). Synthesis and Pharmacological Evaluation of 4-Halo Progesterone Derivatives as Antiandrogen.. Chemical and Pharmaceutical Bulletin. 47(9). 1232–1236. 14 indexed citations
18.
Cabeza, Marisa, et al.. (1993). Evaluation of levonorgestrel action on the flank organ and the sebaceous gland lipogenesis of female hamsters.. PubMed. 41(1-4). 20–7. 6 indexed citations
19.
Cabeza, Marisa, et al.. (1993). El papel de la testosterona y el efecto del levonorgestrel en el metabolismo de lipidos de las glandulas sebaceas. 18(5). 28–32. 2 indexed citations
20.
Cabeza, Marisa, et al.. (1990). Composicion y sintesis de novo de lipidos de la glandula sebacea del hamster hembra. 15(3). 35–38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026